Entinostat

Generic Name
Entinostat
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C21H20N4O3
CAS Number
209783-80-2
Unique Ingredient Identifier
1ZNY4FKK9H
Background

Entinostat is under investigation for the treatment and other of Volunteers, Breast Cancer, Human Volunteers, and Normal Volunteers. Entinostat has been investigated for the treatment of Non-Small Lung Cancer, Epigenetic Therapy.

Indication

联合芳香化酶抑制剂用于治疗激素受体(HR)阳性、人类表皮生长因子受体-2(HER-2)阴性,经内分泌治疗复发或进展的局部晚期或转移性乳腺癌患者。

Associated Conditions
-
Associated Therapies
-
© Copyright 2024. All Rights Reserved by MedPath